News
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Three simultaneous withdrawals—from the World Health Organization, USAID and the Gavi vaccine alliance—represent a ...
While both the Novavax vaccine and the newest generation of the mRNA Moderna vaccines had been signed off on by about 30 FDA vaccine officials, Prasad ended up writing overrides for each, restricting ...
Peter Marks, who headed the FDA’s Center for Biologics Evaluation and Research before being forced to resign in March, said ...
The agency's website indicates HHS Secretary Robert F. Kennedy Jr. adopted the previous advisory panel's suggestion to expand access on June 25. AP also reports on FDA vaccine chief Vinay Prasad's ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
The Department of Health and Human Services under Robert F. During his Senate confirmation hearings, Health Secretary Robert ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results